Fisher Asset Management
CLVS

Fisher Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Fisher Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,062
Closed -$106K – 974
2021
Q1 		$106K Sell
15,062
-32,237
-68% -$216K ﹤0.01% 880
2020
Q4 		$227K Buy
47,299
+410
+0.9% +$2.07K ﹤0.01% 849
2020
Q3 		$273K Buy
46,889
+11
+0% +$66 ﹤0.01% 758
2020
Q2 		$316K Buy
46,878
+67
+0.1% +$507 ﹤0.01% 718
2020
Q1 		$298K Sell
46,811
-34,278
-42% -$275K ﹤0.01% 684
2019
Q4 		$845K Sell
81,089
-39,187
-33% -$285K ﹤0.01% 604
2019
Q3 		$473K Hold
120,276
– – ﹤0.01% 696
2019
Q2 		$1.79M Buy
120,276
+60,725
+102% +$1.1M ﹤0.01% 554
2019
Q1 		$1.48M Buy
59,551
+120
+0.2% +$3.01K ﹤0.01% 554
2018
Q4 		$1.07M Hold
59,431
– – ﹤0.01% 589
2018
Q3 		$1.75M Buy
59,431
+1,125
+2% +$43.6K ﹤0.01% 533
2018
Q2 		$2.65M Buy
58,306
+10,345
+22% +$503K ﹤0.01% 506
2018
Q1 		$2.53M Hold
47,961
– – ﹤0.01% 505
2017
Q4 		$3.26M Buy
47,961
+21,328
+80% +$1.49M ﹤0.01% 478
2017
Q3 		$2.19M Buy
+26,633
New +$2.11M ﹤0.01% 490

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fisher Asset Management's CLVS Position: Q2 2021 in Review

Fisher Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 15,062 shares — an estimated $106K sold.

Fisher Asset Management first reported a position in CLVS in Q3 2017 and held it in 15 quarters. The position peaked at $3.26M in Q4 2017. 161 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • Fisher Asset Management reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • Fisher Asset Management sold 15,062 Clovis Oncology, Inc. shares in Q2 2021, an estimated $106K.
  • Fisher Asset Management first reported a position in Clovis Oncology, Inc. in Q3 2017 and held it in 15 quarters.
  • Fisher Asset Management's Clovis Oncology, Inc. position peaked at $3.26M in Q4 2017.
  • 161 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.